TN Gender-Affirming Care Ban Upheld by SCOTUS
- In a 6-3 decision, the Supreme Court has upheld Tennessee's ban on gender-affirming care for minors, ruling that the ban does not constitute sex-based discrimination.This decision marks a...
- The ruling is expected to have significant implications nationwide, as 27 states currently have bans on gender-affirming hormones, surgery, or both, for transgender youth.
- Initially, the Department of Justice joined the challenge in a Tennessee federal district court, which granted a preliminary injunction on the puberty blocker and hormone ban, while allowing...
The Supreme Court has delivered a notable blow to transgender rights, upholding Tennessee’s ban on gender-affirming care for minors. The court’s decision,ruling the ban is not sex-based discrimination,has broad implications. This ruling impacts access to crucial medical treatments and fuels a national debate surrounding transgender healthcare access. Twenty-seven states have similar bans on gender-affirming hormones and surgeries, leading to expected further litigation.The case, L.W. v. Skrmetti, saw shifting stances from federal administrations. News Directory 3 reports on the key legal arguments, the dissenting opinions, and the anticipated legal fallout. Discover what’s next in this evolving, high-stakes legal landscape.
Supreme Court Upholds Tennessee Ban on Gender-Affirming Care
In a 6-3 decision, the Supreme Court has upheld Tennessee’s ban on gender-affirming care for minors, ruling that the ban does not constitute sex-based discrimination.This decision marks a setback for transgender youth and their families who have been challenging restrictions on their access to care.
The ruling is expected to have significant implications nationwide, as 27 states currently have bans on gender-affirming hormones, surgery, or both, for transgender youth. the decision’s applicability to states suggests further litigation will be necessary concerning federal actions related to this type of care.The case, known as L.W. v. Skrmetti,arose after Tennessee enacted its ban in 2023,prompting a challenge from three families and a medical provider who argued the law violated the 14th Amendment’s equal protection clause.
Initially, the Department of Justice joined the challenge in a Tennessee federal district court, which granted a preliminary injunction on the puberty blocker and hormone ban, while allowing the surgical ban to remain. Though, the state appealed, and the Sixth Circuit ruled that the law did not discriminate based on sex. Later,lawyers for the Biden administration and the American Civil liberties Union petitioned the Supreme Court for review.
During arguments in December, the core question was whether the ban constituted sex-based discrimination, which would necessitate a higher level of judicial scrutiny.Chief Justice John Roberts,writing for the majority,stated that merely referencing sex in the ban was insufficient to trigger heightened scrutiny.
The case’s dynamics shifted when the Trump administration, in early February, altered the Justice Department’s stance to support Tennessee. Furthermore, President Trump signed an executive order aimed at withdrawing federal funds from hospitals providing gender-affirming care to those under 19. Although a federal district court issued a nationwide preliminary injunction against this order in early March, the centers for Medicare and Medicaid Services indicated it would align its policies accordingly. A proposed federal budget bill also seeks to block federal Medicaid funding for gender-affirming care for individuals of all ages.
Nicole Huberfeld, a law professor at Boston University, noted that the decision’s state-level submission means more litigation is needed to extend the same rationale to the federal government. She added that eliminating medicaid funding is a separate issue from discrimination.
What’s next
Further legal challenges are anticipated to determine the extent to which this ruling impacts federal policies and funding related to gender-affirming care.